There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Encompass Health (EHC – Research Report) and Ionis Pharmaceuticals (IONS – Research Report) with bullish sentiments. Encompass Health (EHC) In a report released today, Matthew Borsch from BMO Capital maintained a Buy rating on Encompass Health, with a price target of $75.00. The company's shares closed last Thursday at $61.90. According to TipRanks.com, Borsch is a 4-star analyst with an average return of -6.4% and a 38.4% success rate. Nachman covers the Healthcare sector, focusing on stocks such as Bausch Health Companies, Pacira Pharmaceuticals, and Horizon Therapeutics.
https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-these-healthcare-stocks-encompass-health-ehc-ionis-pharmaceuticals-ions?utm_source=advfn.com&utm_medium=referral
Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart
From Apr 2022 to May 2022 Click Here for more Ionis Pharmaceuticals Charts.
Ionis Pharmaceuticals (NASDAQ:IONS)
Historical Stock Chart
From May 2021 to May 2022 Click Here for more Ionis Pharmaceuticals Charts.